Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22824,179,1.10 [0.77-1.57],0.6060373366529761
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23862,191,0.68 [0.48-0.95],0.0253343376062531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23617,1423,0.87 [0.76-0.99],0.0295607881620504
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Candidiasis,23876,380,0.76 [0.60-0.97],0.0302917564857006
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23181,3493,0.87 [0.80-0.94],0.0005396441507695
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23138,3508,0.90 [0.83-0.98],0.0116027660041194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23660,1053,0.96 [0.83-1.11],0.5865773668612264
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23797,81,0.97 [0.57-1.65],0.9107789989922056
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21648,1127,0.95 [0.82-1.09],0.4519428919782452
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20884,1248,0.82 [0.72-0.94],0.0048238604450451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20606,253,0.79 [0.59-1.06],0.121419257412064
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16800,2285,0.85 [0.77-0.94],0.0013508834134579
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20536,406,0.80 [0.63-1.02],0.0686637458234227
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23866,1259,0.91 [0.79-1.04],0.152173892324532
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,23968,472,0.78 [0.63-0.97],0.0240469279675272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23095,901,0.85 [0.72-0.99],0.0403793461814342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23889,1244,0.97 [0.84-1.11],0.6294265538321465
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22800,193,0.66 [0.47-0.93],0.0171931444350005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24007,53,0.56 [0.29-1.07],0.0780729273888589
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23731,1086,0.96 [0.83-1.11],0.6019261208481836
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23788,72,0.76 [0.44-1.34],0.3483307266854747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23943,119,1.16 [0.75-1.81],0.4956402752845478
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23925,101,1.06 [0.66-1.71],0.796076375480542
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22692,498,1.03 [0.83-1.28],0.7665767380669404
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22482,288,0.71 [0.54-0.94],0.0184941167288193
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22696,89,0.99 [0.60-1.64],0.9713503136818183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23988,70,1.17 [0.67-2.06],0.5775978512833813
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23953,144,0.58 [0.39-0.87],0.0075475921004418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral warts,23861,52,0.40 [0.21-0.76],0.0052792260251698
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23860,51,0.96 [0.49-1.88],0.9041033497430712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,23689,347,1.23 [0.95-1.59],0.1144101697273574
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23935,45,1.33 [0.65-2.70],0.43427059177261
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23901,55,1.55 [0.81-2.95],0.1833890670045433
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23959,131,1.42 [0.94-2.16],0.0989074896498224
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23632,1653,0.94 [0.84-1.06],0.3073514568751808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of meninges,24007,32,1.06 [0.46-2.48],0.8871719812002491
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23943,66,1.05 [0.59-1.90],0.8619014576282913
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23991,78,0.73 [0.43-1.25],0.2535029787296793
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23982,445,1.05 [0.84-1.32],0.670654996152994
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Caecum,23977,340,0.97 [0.75-1.26],0.8288385931995412
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23876,83,0.74 [0.44-1.24],0.2498985625243416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Descending colon,23975,278,0.89 [0.67-1.19],0.4404490482265047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,23935,427,1.06 [0.84-1.34],0.6013600396001955
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23883,732,0.92 [0.77-1.09],0.3292330298671124
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23964,565,0.84 [0.69-1.03],0.0882831406047175
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18653,71,1.66 [0.94-2.93],0.0782700779445302
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18654,72,0.98 [0.55-1.74],0.9480122688203274
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23975,101,0.85 [0.53-1.36],0.4928519557545285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",23975,98,0.84 [0.52-1.36],0.483885388193133
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lung cancer and mesothelioma,15981,344,0.57 [0.44-0.73],1.177474833026344e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lymphoid leukaemia,18647,65,1.17 [0.64-2.14],0.6001292475384961
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18783,201,1.23 [0.87-1.73],0.2447737839877556
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18876,294,1.02 [0.77-1.35],0.8822612732474612
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18673,91,1.49 [0.90-2.46],0.120003662550236
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18727,145,0.76 [0.51-1.13],0.1719152307164262
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18721,139,0.85 [0.57-1.27],0.4387082197872728
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18665,83,1.08 [0.64-1.83],0.777114872205233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",20000,1418,1.11 [0.97-1.26],0.1181188554749578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18728,146,0.87 [0.59-1.29],0.4979789682629905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18689,107,0.78 [0.50-1.24],0.2971615497835257
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18712,130,1.35 [0.88-2.07],0.1633000394395638
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,23878,170,1.22 [0.85-1.76],0.2882828941924906
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of trunk,23974,94,1.18 [0.72-1.94],0.5152383593971765
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanoma in situ,18615,74,0.98 [0.56-1.72],0.9334089480604568
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18683,101,1.14 [0.70-1.84],0.5988643501204594
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18751,169,1.43 [0.99-2.08],0.0562537569952158
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18801,219,0.65 [0.48-0.88],0.0061789458608926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18685,103,1.46 [0.91-2.34],0.1208258600959654
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,23872,140,1.17 [0.78-1.76],0.436598789833833
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19798,1216,1.08 [0.94-1.24],0.2730065581034363
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19876,1294,1.09 [0.95-1.25],0.1994946526172097
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23729,309,1.29 [0.98-1.69],0.0709632000438935
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22262,118,0.62 [0.40-0.96],0.0326075282550483
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23493,73,1.33 [0.75-2.33],0.3254316052043548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23441,2793,0.85 [0.78-0.93],0.0004994956086537
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22725,62,1.04 [0.57-1.89],0.9022565330936464
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23580,53,2.25 [1.18-4.29],0.0138847765274641
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23625,1481,0.79 [0.70-0.89],0.0001726842725702
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23623,1479,0.79 [0.70-0.89],0.0002002877204882
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22248,104,0.83 [0.52-1.33],0.4395529051158944
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23765,1102,0.81 [0.70-0.94],0.0044377164667573
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23631,104,0.83 [0.52-1.32],0.4243447827353118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23497,77,1.35 [0.79-2.32],0.2723383248156191
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23481,61,0.68 [0.37-1.25],0.212641917947846
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23842,315,1.44 [1.10-1.88],0.008600684860986
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23910,48,2.48 [1.28-4.79],0.0070901715648998
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23783,256,1.40 [1.04-1.89],0.0276734629872664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22741,78,0.79 [0.46-1.36],0.399667425922244
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17709,380,0.81 [0.64-1.04],0.1027377628585483
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21954,165,0.90 [0.63-1.28],0.5543448986661045
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21981,192,0.78 [0.56-1.08],0.1364335997996548
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17387,58,0.40 [0.22-0.73],0.00284764768664
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22617,64,0.88 [0.49-1.59],0.6785619428117111
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21840,227,0.79 [0.57-1.08],0.1427607437074554
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23503,622,0.91 [0.75-1.11],0.3490116475415841
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23122,241,0.95 [0.69-1.30],0.7324989145667078
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23050,169,0.83 [0.57-1.21],0.339162228400219
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23699,1146,0.91 [0.79-1.05],0.1910882841408909
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20543,1103,0.87 [0.75-1.00],0.0537751320288366
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17404,75,0.71 [0.41-1.23],0.2217254587094917
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23123,39,0.65 [0.31-1.39],0.2702531625136533
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17604,275,0.81 [0.61-1.09],0.1641303882230184
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17402,73,1.97 [1.12-3.47],0.0183554008555917
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21230,3901,0.78 [0.72-0.84],3.4539928574948016e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17517,188,0.53 [0.38-0.75],0.0003139387193202
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17902,573,0.82 [0.67-1.00],0.0530762744321681
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23947,280,0.88 [0.66-1.17],0.3744233992492565
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23758,91,1.02 [0.61-1.68],0.9501715098563348
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17485,156,0.67 [0.46-0.98],0.0377874473177873
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17395,66,0.74 [0.41-1.35],0.3252666412955903
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23829,745,1.08 [0.91-1.29],0.3756390500011841
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17636,307,0.86 [0.65-1.13],0.2825742966471393
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17714,385,0.87 [0.68-1.12],0.2814298997994987
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18063,734,0.71 [0.59-0.85],0.0001464517794238
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17475,146,0.63 [0.42-0.93],0.0214842908580865
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23751,84,1.08 [0.64-1.83],0.7635137085981185
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17899,570,0.60 [0.49-0.73],5.942652117948082e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17724,395,0.69 [0.54-0.87],0.0020136859490151
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21683,70,0.53 [0.30-0.92],0.0243316628188801
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22557,5228,0.79 [0.74-0.84],4.069070392195499e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23104,20,0.46 [0.16-1.32],0.1504126980535748
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23106,22,1.77 [0.65-4.81],0.2608617795557328
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23832,1797,0.85 [0.76-0.95],0.0057473197440949
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23829,1793,0.85 [0.76-0.95],0.0054626988189334
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23106,22,1.15 [0.42-3.11],0.7842583136511808
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23734,803,0.95 [0.81-1.12],0.5611019420638566
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18957,1628,0.72 [0.64-0.81],6.061749012307775e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23996,268,0.83 [0.62-1.11],0.2161489394608419
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22990,109,0.85 [0.54-1.34],0.4784266912581456
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23006,75,1.11 [0.64-1.91],0.713641299177397
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23013,82,0.89 [0.53-1.51],0.6663355192176137
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17395,66,0.59 [0.33-1.07],0.0818056543474357
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21193,167,1.07 [0.73-1.56],0.7258990017124086
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2530,124,1.62 [1.06-2.47],0.0245953294024576
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2692,319,1.02 [0.78-1.32],0.9033251114920612
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21127,101,0.77 [0.47-1.25],0.2855297406199883
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2486,82,1.63 [0.97-2.73],0.0626218212661703
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23215,2189,0.63 [0.57-0.70],4.961662094511595e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23243,362,0.99 [0.77-1.28],0.9445841217135
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21855,242,1.05 [0.77-1.43],0.7498423679834045
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18135,806,0.68 [0.58-0.81],8.938085213981377e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23884,253,1.29 [0.95-1.74],0.1008443662016076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22771,273,0.66 [0.50-0.88],0.0046070379207361
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,21064,1504,0.76 [0.67-0.86],2.1245939008496167e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22882,384,0.83 [0.65-1.05],0.1224496361223811
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22583,85,0.85 [0.51-1.42],0.5398592166951506
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22747,249,0.82 [0.61-1.11],0.1953170421030022
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14070,2340,0.92 [0.83-1.02],0.1045590891006101
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,AV-block,19302,630,0.84 [0.69-1.02],0.0764828916364174
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23931,542,1.10 [0.90-1.35],0.361682062893379
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiac arrest,11981,251,0.73 [0.54-0.98],0.0393633631327163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18876,204,0.95 [0.68-1.33],0.7727401116452014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18784,112,1.03 [0.66-1.62],0.8954715910505948
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24008,69,0.62 [0.35-1.10],0.1038387227917201
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,20047,1375,0.87 [0.77-1.00],0.0423627145133289
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22185,2649,0.84 [0.76-0.92],0.0002406864095316
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20219,7823,0.82 [0.78-0.86],6.312781272019947e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22772,276,1.29 [0.97-1.73],0.0813759555649052
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Endocarditis,18759,87,0.72 [0.43-1.21],0.2178412868058269
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23695,1343,0.96 [0.84-1.09],0.5438165252847833
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,21423,6811,0.79 [0.74-0.83],8.4386782790112595e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21447,6835,0.79 [0.74-0.84],1.1540575265752717e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23776,113,1.08 [0.69-1.69],0.7456902574678739
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14798,186,0.62 [0.44-0.88],0.0071745956252496
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14783,171,0.65 [0.45-0.94],0.0213579735376342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,23859,1246,0.86 [0.75-0.98],0.0276265049999741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22926,116,1.02 [0.65-1.59],0.9306988766553332
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22324,2764,0.84 [0.76-0.92],0.000130312000411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23572,659,0.76 [0.63-0.91],0.0031445126305415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Left bundle-branch block,19093,421,0.99 [0.78-1.26],0.9460210903398674
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23272,1071,0.83 [0.72-0.96],0.0146026898775049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20490,930,0.88 [0.75-1.03],0.1151439326311885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23845,225,0.87 [0.64-1.20],0.4038795965263292
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23955,375,0.81 [0.63-1.03],0.0901171871701158
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Oesophageal varices,22566,70,1.06 [0.60-1.89],0.8313927414649692
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other aneurysm,22596,98,0.67 [0.42-1.08],0.0991776972119732
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,19160,488,1.07 [0.86-1.33],0.5351574596707287
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22633,135,0.77 [0.52-1.16],0.2144288563083405
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22780,282,0.71 [0.54-0.94],0.0179409153172847
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18870,198,1.00 [0.71-1.41],0.9951477755287264
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other disorders of veins,22595,99,1.00 [0.62-1.62],0.992143732048968
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22548,52,0.77 [0.40-1.48],0.433400966855615
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22404,91,0.68 [0.41-1.13],0.1357238917155371
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22602,106,1.31 [0.83-2.08],0.2455243700174934
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19933,1261,0.98 [0.85-1.12],0.7495958183439908
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22679,66,1.00 [0.56-1.80],0.9906799786077288
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23076,578,0.84 [0.69-1.02],0.0838274200088413
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23358,367,0.83 [0.65-1.07],0.1552046787620673
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22987,674,0.76 [0.63-0.91],0.0034950380085215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,12117,387,1.02 [0.79-1.30],0.9006589028634043
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22985,536,0.83 [0.68-1.01],0.0673647885086403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22853,357,1.13 [0.88-1.46],0.3428965719825688
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23494,503,0.98 [0.79-1.21],0.8522316410540898
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23945,719,1.10 [0.92-1.31],0.3188308995100185
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Right bundle-branch block,19148,476,0.85 [0.68-1.05],0.1365958754963219
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23356,365,0.84 [0.65-1.08],0.1660592888001125
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22537,224,0.84 [0.61-1.15],0.2799178544444888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23556,746,0.78 [0.66-0.93],0.0057770761086858
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23540,775,0.79 [0.66-0.93],0.0059833876285118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22903,47,0.76 [0.38-1.52],0.4336794437208424
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22612,115,1.13 [0.72-1.76],0.6030770106829493
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23163,250,0.69 [0.51-0.94],0.0171975256903002
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22519,318,0.67 [0.52-0.88],0.0038478854546407
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,22879,383,1.26 [0.98-1.60],0.0694378883694082
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22515,75,0.63 [0.36-1.08],0.0942524827539545
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23769,788,0.99 [0.84-1.18],0.9220608987952276
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23808,499,0.94 [0.76-1.15],0.5324086247229698
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20636,972,0.92 [0.79-1.07],0.2583104514670937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,23312,3648,0.84 [0.78-0.91],1.3990169306127176e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23745,589,0.99 [0.82-1.21],0.953207623560547
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20846,1182,0.86 [0.75-0.99],0.0338409358500787
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19749,85,1.04 [0.63-1.73],0.8677663743572077
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,23360,1541,0.69 [0.62-0.78],2.330950586236281e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21543,1879,0.75 [0.68-0.83],2.1466382211993644e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Vascular dementia,23496,152,0.76 [0.51-1.12],0.1683991173828736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Alzheimer disease,24006,297,0.96 [0.72-1.27],0.7746102451442451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15952,58,1.07 [0.56-2.07],0.8324504945057378
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Bell's palsy,22620,78,1.07 [0.62-1.84],0.8191521576839094
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22888,346,0.83 [0.64-1.08],0.1656204421982112
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral cysts,23599,237,0.88 [0.64-1.20],0.4067245072629432
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23920,364,0.85 [0.66-1.09],0.1886422189271759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23496,59,0.87 [0.46-1.62],0.652474097687747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23987,73,0.49 [0.28-0.85],0.0112646057365313
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23454,92,0.71 [0.43-1.15],0.1635636807757489
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,22373,289,0.91 [0.69-1.20],0.509309946350067
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23463,1379,0.84 [0.74-0.95],0.0078190921376618
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23971,690,0.85 [0.71-1.03],0.0931290490372499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23453,2222,0.95 [0.86-1.05],0.3508317135256732
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Generalized epilepsy,23614,60,0.68 [0.37-1.25],0.2183204431113097
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,23836,280,0.83 [0.63-1.10],0.2030473297205635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hydrocephalus,23417,55,0.50 [0.27-0.93],0.0291562133926342
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23989,60,0.99 [0.54-1.85],0.987031562502793
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22563,21,1.21 [0.42-3.43],0.7251148721511881
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22636,94,0.95 [0.58-1.55],0.8359641304575267
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Memory loss,23333,120,1.12 [0.72-1.74],0.6046634499312855
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,22284,200,0.84 [0.60-1.17],0.3019068060616393
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23983,180,0.92 [0.64-1.32],0.6463007828342217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Motor neuron disease,16060,153,0.94 [0.63-1.39],0.7418861908120179
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23895,65,1.03 [0.57-1.86],0.9176451689557426
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23530,988,0.90 [0.78-1.05],0.1902767063519979
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,22675,3702,0.88 [0.82-0.96],0.0021452138869758
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23679,242,0.73 [0.54-1.00],0.0466299312726163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22937,395,0.83 [0.65-1.05],0.1234262259209371
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23914,360,1.17 [0.91-1.50],0.229147418920177
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18817,624,0.87 [0.71-1.05],0.1497642626054434
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23443,81,1.10 [0.65-1.87],0.7283595421138477
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23518,156,0.54 [0.37-0.79],0.001573103076397
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23422,141,0.81 [0.54-1.21],0.3088713658691542
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22639,97,1.08 [0.66-1.75],0.7667317937689548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other headache syndromes,22123,39,1.09 [0.50-2.36],0.8277612826754411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,23888,526,0.76 [0.62-0.93],0.008850523111047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,22794,710,0.76 [0.63-0.91],0.0027531343405534
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Parkinson's disease,23985,541,0.93 [0.75-1.14],0.4740011640249485
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23388,26,0.99 [0.38-2.56],0.9885235129907536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Restless leg syndrome,24007,51,0.70 [0.36-1.37],0.2991031313098565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,23700,640,0.79 [0.65-0.95],0.0136876329463051
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,59,2.06 [1.11-3.81],0.0218189515663004
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23989,179,0.93 [0.65-1.32],0.6745426808997022
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22577,35,0.81 [0.36-1.83],0.6172475605886849
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24006,300,0.97 [0.73-1.28],0.8239556755471338
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23465,148,0.78 [0.52-1.16],0.2223170540564451
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23453,86,0.76 [0.46-1.27],0.2971382940921899
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23658,303,0.76 [0.58-1.00],0.0536473868787305
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23806,293,0.66 [0.50-0.88],0.003743994814948
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23125,44,1.25 [0.60-2.61],0.5469615929507132
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23143,62,0.79 [0.43-1.45],0.44879847062189
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23913,43,0.51 [0.25-1.03],0.0619838184857903
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23772,125,0.79 [0.51-1.21],0.272484949566441
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2490,84,1.63 [0.98-2.71],0.0576992518357501
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3030,132,1.80 [1.20-2.70],0.0041441360255306
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23463,96,0.89 [0.55-1.46],0.64683101818074
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23754,1002,0.89 [0.77-1.04],0.1443770819517632
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23700,619,0.81 [0.67-0.99],0.0361439203601456
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23227,146,0.85 [0.57-1.26],0.4077925267793564
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23931,576,0.84 [0.69-1.03],0.0939798802792381
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24004,66,0.69 [0.38-1.23],0.2088383826722895
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23862,507,0.82 [0.67-1.02],0.0754427660198327
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23968,321,0.82 [0.63-1.08],0.1554613259142748
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23917,149,0.92 [0.62-1.36],0.6632609860508463
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23160,79,0.60 [0.35-1.02],0.0597369662738604
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23166,85,0.58 [0.35-0.97],0.0382253873295564
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23125,44,1.03 [0.50-2.14],0.93857654838973
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23911,681,0.83 [0.69-0.99],0.0413259877207474
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23412,182,0.72 [0.50-1.02],0.0656526027303321
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23385,30,0.84 [0.35-2.03],0.7014922722527704
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23744,97,0.87 [0.54-1.42],0.5821958583045962
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23877,230,0.81 [0.59-1.10],0.1785246006510409
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23526,171,0.96 [0.67-1.39],0.8429048362199522
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23851,83,0.75 [0.44-1.26],0.2769873504525191
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23690,460,0.73 [0.59-0.91],0.0059876281817149
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23496,129,0.84 [0.55-1.28],0.4148471239505664
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22625,1805,0.84 [0.75-0.94],0.0026770137371349
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23846,199,0.86 [0.61-1.22],0.4015435497291318
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23991,146,0.94 [0.63-1.40],0.756434849747091
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23500,419,0.78 [0.62-0.98],0.0348254131659757
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23712,65,0.79 [0.44-1.42],0.4293627471697149
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23993,55,0.77 [0.41-1.46],0.4223934332588185
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23159,78,0.91 [0.53-1.57],0.7318990790417965
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23222,141,1.05 [0.70-1.57],0.8240684081543977
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22880,128,0.84 [0.55-1.29],0.4346315513581595
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23406,51,1.06 [0.54-2.08],0.8558362561639257
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22817,65,0.76 [0.42-1.39],0.379204122149252
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23283,53,0.94 [0.49-1.82],0.8555254943015669
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23440,210,0.75 [0.54-1.04],0.0887797713688688
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23199,118,0.77 [0.50-1.20],0.2447177966414175
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22874,122,0.92 [0.59-1.42],0.7002766458351799
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22847,95,1.01 [0.62-1.65],0.9729658536638496
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22300,1480,0.86 [0.76-0.98],0.0209754237530066
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23139,58,0.86 [0.46-1.62],0.6347538930581482
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23758,391,0.86 [0.68-1.10],0.2336689157631488
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23437,70,1.16 [0.66-2.04],0.6008190069574375
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23536,169,1.28 [0.89-1.85],0.1845491073798162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23828,57,0.94 [0.50-1.79],0.8549139872294418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23965,121,0.95 [0.61-1.46],0.8023575538956944
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23872,113,1.30 [0.83-2.04],0.2496274414600935
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23821,50,1.48 [0.75-2.91],0.2538002050999934
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23825,54,0.77 [0.40-1.47],0.4246231696609641
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23913,979,0.78 [0.67-0.91],0.0015902447245896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23661,727,0.84 [0.70-1.00],0.048928724341027
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23065,131,0.69 [0.45-1.05],0.0824938913385595
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23020,86,0.76 [0.45-1.27],0.2943961626705604
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute pharyngitis,23793,63,1.20 [0.66-2.17],0.5551408020150007
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23921,191,1.10 [0.78-1.56],0.5749262808670171
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23792,62,1.05 [0.57-1.93],0.8775403098949756
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza,21702,108,0.93 [0.59-1.49],0.7700021627820084
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21699,105,0.95 [0.59-1.52],0.8368410230817408
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15744,107,0.93 [0.58-1.48],0.7561289448940708
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic rhinitis,23898,267,1.03 [0.77-1.38],0.851437786546746
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16737,1451,0.87 [0.77-0.99],0.0289343635475347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17061,1424,0.86 [0.76-0.98],0.0244210896472491
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23617,151,0.81 [0.55-1.18],0.2703263941873093
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21690,96,0.66 [0.41-1.07],0.0932992921829958
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bronchiectasis,20868,289,0.65 [0.49-0.86],0.0028312666665636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20623,44,0.69 [0.34-1.39],0.301752850910426
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23151,2572,0.81 [0.74-0.89],8.764694920088829e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22554,80,1.07 [0.63-1.82],0.8108581254240815
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,22637,163,0.83 [0.57-1.20],0.3262799720537905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23782,1307,0.72 [0.63-0.82],4.253817876440484e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,22615,141,0.59 [0.40-0.88],0.0089631219508578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21983,5316,0.90 [0.84-0.96],0.0020437571321358
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22866,392,0.70 [0.55-0.89],0.0033241320212255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,22784,309,0.51 [0.40-0.66],2.045747801527437e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Emphysema,20930,351,0.55 [0.43-0.70],1.5247987809133565e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23069,342,0.43 [0.33-0.56],9.564865907345083e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23757,2163,0.82 [0.74-0.91],0.0002017561478769
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,23097,370,0.47 [0.37-0.61],2.553346098476474e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Later onset COPD,22930,998,0.78 [0.68-0.91],0.0013780809020166
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23989,430,0.91 [0.72-1.15],0.4227033946883453
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,22621,147,1.21 [0.82-1.79],0.3391053524168457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23735,1011,0.87 [0.75-1.01],0.0772153376675686
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,23724,2208,0.87 [0.79-0.96],0.0066534322723865
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23347,873,0.96 [0.81-1.12],0.5886947092346908
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other pleural conditions,21580,64,0.74 [0.41-1.34],0.3202964935970627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23911,454,0.58 [0.46-0.72],1.117186126113307e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23883,1396,0.85 [0.75-0.97],0.0141043459034223
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,22646,1130,0.91 [0.79-1.05],0.2118815840040548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural plaque,21781,265,0.72 [0.54-0.97],0.0287921562414747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23491,1897,0.83 [0.75-0.93],0.0010830016794633
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23888,329,0.91 [0.70-1.19],0.5041735234198144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumothorax,21658,142,0.60 [0.41-0.89],0.0103673504800821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pollen allergy,23991,232,1.04 [0.76-1.43],0.8018659025762419
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pulmonary oedema,23525,68,1.28 [0.72-2.29],0.3964770635836617
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15693,56,0.70 [0.38-1.30],0.2608977700205331
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23717,993,0.88 [0.75-1.02],0.0865144890048552
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22743,269,1.02 [0.76-1.37],0.8754037929494947
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Viral pneumonia,21878,284,0.72 [0.54-0.95],0.0219693943392254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23635,241,0.70 [0.52-0.95],0.023916796734762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10463,115,0.67 [0.43-1.05],0.078587523837154
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16763,89,1.16 [0.70-1.93],0.5654766175294674
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,23871,146,1.16 [0.78-1.72],0.4672373130790239
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute gastritis,18117,91,1.00 [0.60-1.65],0.9953244895711784
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,22643,203,0.90 [0.64-1.26],0.5458239456205042
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute peritonitis,23642,101,1.16 [0.72-1.87],0.5492313331848255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23104,116,1.06 [0.69-1.63],0.798565559164419
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Barrett oesophagus,18560,534,0.85 [0.69-1.04],0.1167329704969194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22562,122,0.76 [0.49-1.17],0.2104066618017248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23599,122,0.75 [0.48-1.15],0.1863144566599865
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,22659,219,0.99 [0.72-1.37],0.9677411190753552
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,23230,790,1.08 [0.91-1.29],0.3561451693407547
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,18293,267,1.08 [0.81-1.45],0.601854078860578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22498,58,0.57 [0.31-1.05],0.0699898846707353
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23799,136,1.33 [0.88-2.00],0.1762129955444087
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,22363,93,0.86 [0.52-1.41],0.5397818851897536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Collagenous colitis,22560,50,0.80 [0.41-1.56],0.510536392478698
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23841,221,0.95 [0.69-1.31],0.764522304766841
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,23842,1607,0.84 [0.74-0.94],0.0033598513678014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,22603,93,0.47 [0.29-0.76],0.0019486257386631
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23663,67,0.57 [0.32-1.01],0.0554446889351053
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22588,78,0.51 [0.30-0.86],0.0114090188652071
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,23357,227,0.73 [0.54-1.00],0.0487319306400779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20324,1957,0.90 [0.80-1.00],0.0471289849875632
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,23903,178,1.14 [0.80-1.63],0.4789155834934105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,23865,877,0.95 [0.81-1.12],0.5338293443391096
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21993,3967,0.91 [0.84-0.98],0.0171156641251988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23645,515,0.90 [0.73-1.11],0.3288736637236221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23957,416,1.11 [0.88-1.41],0.3794788494789287
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23241,111,0.86 [0.55-1.34],0.4993738587166828
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23097,67,1.03 [0.58-1.84],0.9173212479664414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23688,1418,0.85 [0.75-0.96],0.010341912657084
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of tongue,23117,110,0.65 [0.42-1.02],0.0632279182933639
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23633,1193,1.02 [0.89-1.17],0.7827609118469684
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19742,3068,0.84 [0.77-0.92],0.0001381703671949
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,18295,269,0.79 [0.59-1.06],0.1134790837038064
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23890,211,0.71 [0.51-0.98],0.0355208254197479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23932,47,0.79 [0.40-1.56],0.4930911550230449
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23147,159,1.21 [0.83-1.78],0.314725410105763
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16855,181,1.00 [0.70-1.44],0.9878923216669264
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,18455,429,0.87 [0.69-1.10],0.2387383345991473
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,18395,369,0.77 [0.60-0.99],0.0423150530694
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20205,2179,0.93 [0.84-1.04],0.1988149974424654
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18628,602,0.77 [0.63-0.93],0.0079486777109035
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18358,8048,0.94 [0.89-1.00],0.0356410847595313
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,23449,1179,0.87 [0.76-1.00],0.0558193274146592
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23176,46,1.09 [0.54-2.19],0.8176851150605798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17646,1245,0.96 [0.84-1.10],0.5564672603958538
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23076,88,1.31 [0.79-2.17],0.3000548646482525
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,21935,3568,0.95 [0.88-1.03],0.2483290886664441
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,23935,44,0.78 [0.38-1.58],0.4832226863934606
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impaction of intestines,16721,47,1.12 [0.56-2.25],0.7548445392376558
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,20017,1650,0.94 [0.84-1.06],0.3013992207406919
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18567,200,1.03 [0.73-1.45],0.8728442533426083
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16765,91,0.72 [0.44-1.19],0.1995936392085225
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22376,106,0.78 [0.49-1.23],0.2847416135185151
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16946,272,0.77 [0.58-1.04],0.0846443607750183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23965,380,0.86 [0.67-1.09],0.2088655104490926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23192,682,0.92 [0.77-1.11],0.3966744239349435
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23404,894,0.93 [0.79-1.09],0.3686848977557595
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18242,216,0.87 [0.63-1.20],0.4033557944440132
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,18661,635,0.92 [0.76-1.12],0.4138140127397987
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23954,115,0.96 [0.62-1.50],0.8686552202862399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18446,79,0.82 [0.48-1.41],0.4708866332663681
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18117,1443,0.94 [0.83-1.07],0.3527708554426867
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22699,259,0.80 [0.60-1.08],0.1506998936455347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22564,124,0.97 [0.63-1.49],0.8848531298371469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,18565,1891,0.91 [0.82-1.02],0.1095901803923475
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,22180,5506,0.89 [0.83-0.95],0.0004383671207616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23080,181,0.84 [0.59-1.19],0.3318500339179289
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,23688,700,0.97 [0.81-1.16],0.7550705439198888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18772,746,0.77 [0.65-0.92],0.0037986545786674
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22583,143,0.91 [0.61-1.36],0.6587658413290781
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23883,342,1.01 [0.78-1.32],0.9126388516124158
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18835,809,0.93 [0.78-1.10],0.3948555787968909
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23461,1191,0.88 [0.77-1.01],0.0712338893957201
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23310,180,0.94 [0.66-1.34],0.7420150251434895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18319,1645,0.82 [0.73-0.92],0.0009517128846719
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19909,1883,0.90 [0.80-1.00],0.0494294768981901
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23087,99,0.78 [0.48-1.27],0.3209317314527607
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23292,782,0.90 [0.76-1.07],0.2357980033400467
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17028,354,0.88 [0.68-1.14],0.3329114625465306
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23923,56,0.63 [0.34-1.18],0.1529685926136672
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17154,480,0.79 [0.63-0.98],0.0348698897072144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22436,166,0.62 [0.43-0.89],0.0093093679456568
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23993,44,1.09 [0.53-2.25],0.8067794388363143
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23139,108,0.82 [0.52-1.30],0.4064073854590974
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Toxic colitis,22557,47,0.98 [0.48-1.99],0.958533749607108
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18324,298,0.71 [0.54-0.94],0.0152577455344481
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,22660,150,1.01 [0.68-1.49],0.9799245810959768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22636,126,0.97 [0.63-1.48],0.8736942087853676
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,18741,374,1.00 [0.78-1.28],0.9941444381487768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16833,159,0.87 [0.60-1.28],0.4923243697731905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,18634,267,1.08 [0.80-1.44],0.6187685512667678
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Volvulus,16747,73,0.72 [0.41-1.27],0.253967308664588
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23930,332,0.92 [0.71-1.20],0.5471244405717659
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23684,69,1.20 [0.67-2.14],0.5396229599771905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21994,98,1.44 [0.89-2.34],0.1408718703178107
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23266,767,1.05 [0.88-1.25],0.5806880876851677
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22702,203,0.65 [0.47-0.90],0.0098560173109105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22369,473,0.94 [0.76-1.17],0.5833092535735691
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23710,269,0.78 [0.58-1.05],0.0990174785692245
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23917,476,0.78 [0.63-0.97],0.0275218847742064
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23486,45,0.88 [0.43-1.81],0.7287195157074442
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22510,3211,0.97 [0.89-1.06],0.4814826293314785
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23555,410,1.07 [0.85-1.35],0.5729507449322025
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23441,296,1.02 [0.77-1.34],0.8920436138096502
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23544,1045,0.94 [0.81-1.09],0.4051017418693372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23997,31,1.01 [0.43-2.39],0.9784052527383365
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21919,23,0.82 [0.55-1.21],0.3093346521167396
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23203,58,1.63 [0.87-3.06],0.1307729291159601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23705,264,0.80 [0.60-1.08],0.1446112427636273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22382,486,0.96 [0.77-1.19],0.7097171926283863
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21976,80,1.53 [0.90-2.60],0.1143164286147056
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23940,83,1.38 [0.82-2.32],0.2292342580230675
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22718,219,0.89 [0.64-1.23],0.4669159640641008
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23835,220,0.85 [0.61-1.17],0.3045140026912488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23513,72,1.11 [0.63-1.95],0.721683427524308
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21964,68,1.31 [0.73-2.34],0.3669046735231918
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23546,1650,1.03 [0.91-1.16],0.6513773843732671
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22423,527,0.97 [0.78-1.19],0.7594848881305135
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21979,83,1.51 [0.90-2.55],0.1182293050852162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23916,301,0.95 [0.72-1.26],0.7416194640857454
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23495,54,0.60 [0.31-1.13],0.1121069358032474
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23879,264,0.94 [0.70-1.27],0.7028017861671383
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23950,352,0.92 [0.71-1.20],0.5497429310750606
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21987,91,1.42 [0.86-2.34],0.1753790572071893
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22169,273,1.05 [0.78-1.40],0.7662875072800405
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23943,345,0.90 [0.70-1.17],0.4454561103970302
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22167,271,1.17 [0.88-1.56],0.2886062824131917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23982,125,1.03 [0.67-1.57],0.8995139089896518
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20730,92,1.21 [0.73-1.99],0.455314930141124
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21908,4817,0.96 [0.90-1.03],0.2653812332931569
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20488,3397,0.90 [0.83-0.98],0.0165867967870178
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20708,70,1.43 [0.81-2.53],0.2173458278239381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21080,153,0.84 [0.57-1.23],0.3711592213833672
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21071,144,1.14 [0.76-1.69],0.5300812582839842
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23803,68,1.01 [0.57-1.78],0.9830006525121476
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21007,80,0.97 [0.57-1.65],0.9139151881917852
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17969,878,0.92 [0.78-1.08],0.2959066122082344
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23889,152,1.18 [0.80-1.75],0.4024753652539187
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21201,274,0.93 [0.70-1.25],0.6401063962968498
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20433,6310,0.94 [0.88-1.00],0.0348359428308105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22937,92,1.45 [0.88-2.37],0.143340359564655
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20805,167,0.71 [0.49-1.03],0.0688114896926506
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21076,438,0.84 [0.67-1.06],0.1472993980465917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23178,2251,0.92 [0.83-1.01],0.0886690025664433
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21004,366,1.00 [0.77-1.28],0.9689287604012762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20691,53,0.51 [0.27-0.97],0.0387860001925984
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20732,94,0.62 [0.38-1.01],0.0549122784099646
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23690,31,0.76 [0.32-1.78],0.5223114655503076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18569,1478,0.88 [0.77-1.00],0.0441505610881608
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18085,994,1.21 [1.04-1.41],0.0144576412941053
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23867,980,1.22 [1.04-1.42],0.0125579227154185
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,17140,49,1.23 [0.61-2.45],0.5653751093301536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17170,79,1.67 [0.97-2.87],0.0622359845163391
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20912,274,1.16 [0.87-1.55],0.324310785246662
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17726,635,1.33 [1.10-1.61],0.003528344231943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20970,43,0.77 [0.38-1.58],0.4798045645180347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21459,532,0.89 [0.72-1.09],0.2663232401353919
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21197,270,0.88 [0.66-1.18],0.4060325455958959
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17685,594,1.30 [1.07-1.59],0.0089537390643017
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20704,66,0.49 [0.28-0.87],0.0150995635300013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20692,54,0.79 [0.42-1.50],0.4664897228541821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22939,94,0.81 [0.50-1.33],0.4059858504056766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23715,870,0.85 [0.73-1.00],0.0516789723341244
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23252,407,0.81 [0.64-1.02],0.0728847949151546
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23923,288,1.04 [0.78-1.38],0.7874858475385695
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18987,1896,0.93 [0.83-1.04],0.2201201293850092
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,17141,50,0.99 [0.50-1.98],0.9816471389878548
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20721,83,0.91 [0.54-1.53],0.7170228444693425
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,17146,55,0.91 [0.47-1.77],0.7831615035973221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),17136,45,1.23 [0.60-2.53],0.5717227566662146
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23031,186,0.95 [0.67-1.35],0.7923033369596286
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23009,164,0.71 [0.49-1.03],0.0723656441621612
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23972,87,0.96 [0.57-1.59],0.8605469485896651
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22463,1536,0.90 [0.80-1.02],0.0991495446490362
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20705,67,1.38 [0.77-2.48],0.2754642661147722
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),17132,41,2.30 [1.09-4.85],0.0285476198071426
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21547,620,0.77 [0.64-0.94],0.0087520230155318
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18815,1724,1.07 [0.96-1.21],0.2293468645950489
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23715,56,0.74 [0.39-1.39],0.3434293422100579
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23989,63,1.14 [0.62-2.08],0.6773039297812278
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20720,82,1.36 [0.81-2.30],0.2443966615021171
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21630,992,1.00 [0.86-1.16],0.952549284709698
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20734,96,0.76 [0.47-1.23],0.2670841580097924
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18309,1218,0.82 [0.71-0.94],0.0044727893992584
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22931,86,1.16 [0.69-1.93],0.5806057378375047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20682,44,1.23 [0.60-2.53],0.5687264854392349
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21040,113,0.46 [0.30-0.72],0.0006760196264509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21144,506,1.09 [0.88-1.35],0.4206952372197419
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23852,193,1.09 [0.77-1.54],0.6450217245026203
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21412,485,0.95 [0.77-1.19],0.6733230671317649
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23932,282,1.01 [0.76-1.34],0.9647167606888848
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23992,39,0.44 [0.21-0.91],0.0273275044261099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20791,153,0.91 [0.62-1.33],0.615640838372072
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19687,578,0.78 [0.64-0.95],0.0135378556177895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21125,487,1.02 [0.82-1.27],0.8379733591733359
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20969,331,0.99 [0.76-1.28],0.9236407407802256
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",17122,31,0.58 [0.24-1.38],0.2154336424605315
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19381,2290,0.96 [0.87-1.06],0.405851605276943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17545,454,0.85 [0.68-1.07],0.161401030726812
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23823,164,0.93 [0.63-1.36],0.6969738599815819
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23933,48,1.04 [0.52-2.08],0.9200304004842684
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22001,46,0.86 [0.42-1.77],0.6904226509726699
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,17156,65,1.14 [0.62-2.08],0.6703527638351454
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21016,89,0.66 [0.40-1.09],0.1050912556681071
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17387,296,1.05 [0.79-1.39],0.7438411280596418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20916,278,1.10 [0.82-1.47],0.5176140814995386
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21147,220,0.82 [0.59-1.14],0.2341051942218047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21020,93,0.80 [0.48-1.32],0.377476778564825
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,19055,31,0.56 [0.24-1.30],0.175323712197419
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23993,40,0.38 [0.18-0.77],0.0078124834926721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21170,532,1.18 [0.96-1.45],0.1154969716085347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23678,19,1.85 [0.62-5.50],0.2666736635604077
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22924,2286,0.99 [0.90-1.10],0.8901255373468103
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20745,107,1.00 [0.63-1.58],0.9871094476350896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21437,510,0.79 [0.64-0.98],0.0342321776983486
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22939,200,0.57 [0.41-0.80],0.0011548448171964
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21058,131,1.26 [0.83-1.93],0.2780816834879918
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22253,1326,0.88 [0.77-1.01],0.0631778273604618
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21755,828,1.00 [0.84-1.18],0.9595178300861156
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20681,43,0.88 [0.42-1.84],0.7396649045459819
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23697,38,0.65 [0.30-1.38],0.2611349947994092
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20759,121,0.95 [0.61-1.46],0.8086816594462407
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20661,23,0.65 [0.24-1.74],0.3913902822199393
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),17151,60,1.07 [0.58-1.98],0.8359117852046336
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22997,1883,0.97 [0.87-1.09],0.6315676587135891
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23525,413,0.86 [0.68-1.09],0.2088676403968199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23252,140,0.97 [0.65-1.46],0.8975727635442907
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22666,1552,0.89 [0.79-1.01],0.0739090592712999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23752,86,1.97 [1.18-3.30],0.0094234590979095
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23724,360,1.01 [0.78-1.30],0.968122269187522
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,21107,212,0.83 [0.59-1.15],0.2531356277997434
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dialysis,21220,106,1.89 [1.19-2.99],0.0068780011880164
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22714,3350,0.96 [0.88-1.04],0.3444477927943969
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21612,5624,0.94 [0.88-1.00],0.0435246534247399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23770,104,1.01 [0.63-1.62],0.9677720685615884
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydrocele,19574,210,0.97 [0.69-1.35],0.8442471436701293
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21220,374,0.93 [0.72-1.19],0.5509007966775168
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,22000,2636,0.95 [0.87-1.05],0.3143905756927808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19598,234,1.07 [0.78-1.47],0.6676424159293166
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20975,80,0.69 [0.41-1.18],0.1723796743209838
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19475,111,0.99 [0.63-1.55],0.9516315994151608
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23995,61,1.06 [0.57-1.95],0.8614390817250551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24000,57,0.71 [0.38-1.32],0.2744229349242748
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23168,2273,0.98 [0.89-1.09],0.7483385947334924
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21854,959,0.94 [0.80-1.10],0.4270693190240138
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23931,567,0.90 [0.74-1.10],0.3110891090976787
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19677,313,0.87 [0.66-1.13],0.2930401885234138
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19645,281,1.00 [0.75-1.33],0.979018428231884
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19597,233,1.11 [0.81-1.52],0.5111343025497219
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23990,49,1.44 [0.73-2.85],0.2943745575128954
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22442,1547,0.98 [0.87-1.11],0.753222809269015
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21266,420,0.91 [0.72-1.15],0.4402598051943448
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23555,191,0.76 [0.54-1.07],0.1204874276146463
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23725,59,0.75 [0.40-1.39],0.3553558485088032
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19634,270,1.00 [0.75-1.35],0.9767677245946308
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23702,2856,0.94 [0.86-1.03],0.1774987020901829
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20921,75,0.44 [0.26-0.76],0.0030817355989666
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21273,159,0.91 [0.62-1.33],0.6256484715034218
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23190,78,0.68 [0.40-1.17],0.1627647928134803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21194,299,0.91 [0.69-1.21],0.5205381547798358
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23642,530,0.91 [0.74-1.12],0.3727522274414283
